Results

Total Results: 788 records

Showing results for "proportion".

  1. effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
    January 01, 2012 - The incidence of adverse events was similar with ivacaftor and placebo, with a lower proportion of
  2. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
    October 01, 2007 - PCI increased along with the proportion of internal mammary artery grafts used, but this trend was not
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
    March 01, 2013 - The same is true for the proportion of patients achieving a minimum clinically important difference
  4. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
    April 20, 2022 - consecutive citations (this sample size is chosen because the upper 97.5% confidence interval bound for a proportion
  5. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
    April 25, 2022 - consecutive citations (this sample size is chosen because the upper 97.5% confidence interval bound for a proportion
  6. effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Tympanostomy Tubes in Children With Otitis Media Draft review available for public comment from July 20, 2016 to August 11, 2016. R…
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
    May 05, 2017 - Disposition of Comments CER 185 Tympanostomy Tubes in Children With Otitis Media Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Tympanostomy Tubes in Children With Otitis Media Draft review available for public comment from July 20, 2016 to August 11, 2016. R…
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
    February 16, 2011 - Reduction in pain i) At least 50 percent reduction ii) At least 30 percent reduction iii) Proportion
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
    September 23, 2016 - Overall/any adverse events (rate or proportion) Source: www.effectivehealthcare.ahrq.gov Published
  10. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
    April 01, 2012 - The incidence of adverse events was similar with ivacaftor and placebo, with a lower proportion of
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
    January 30, 2012 - stage for English language and determine whether this exclusion criterion should be revisited if the proportion
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-adolescents_research-protocol.pdf
    March 29, 2011 - Methods may include setting a minimum proportion of individuals with ASD that must be included in the
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
    February 11, 2013 - population, and may also include discussion of the relevance of the present results vis a vis the proportion
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
    November 27, 2012 - Pg 26: A lower proportion of ustekinumab treatment courses resulted in complete remission (6 percent
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_disposition-comments.pdf
    November 06, 2012 - the effects of the examined physical therapy interventions across the studies according to reported proportion
  16. S158 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
    October 01, 2007 - ORIGINAL ARTICLE Adjustments for Unmeasured Confounders in Pharmacoepidemiologic Database Studies Using External Information Til Stürmer, MD,*† Robert J. Glynn, PhD,*†‡ Kenneth J. Rothman, DrPH,*§¶ Jerry Avorn, MD,* and Sebastian Schneeweiss, MD*� Background: Nonexperimental studies of drug effects in large automa…
  17. effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
    January 01, 2010 - 45 Abstract Characterization of exposure is a central issue in the analysis of observational data; however, no “one size fits all” solution exists for exposure measurement. In this chapter, we discuss potential exposure measurement approaches for observational comparative effectiveness research (CER). First, it is …
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
    March 11, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: March 11, 2010 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Comparative Effectiveness of Core-Needle and Open Surgical Biopsy for…
  19. effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
    January 01, 2012 - insulin is widely available and relatively inexpensive, it would likely be accessible to a sizable proportion
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure-future_research.pdf
    August 01, 2012 - Importance: • Represents a significant disease burden, large proportion or priority population. … • Is of high public interest; affects health care decision-making, outcomes, or costs for a large proportion

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: